Wonder Drug: The Secret History of Thalidomide in America and Its Hidden Victims
Jennifer Vanderbes
“A shocking saga of pharmaceutical malpractice . . . Wonder Drug is both a first-rate medical thriller and the searing account of a forgotten American tragedy.”—Patrick Radden Keefe, author of Empire of Pain A “fascinating and compassionate” (People) account of the most notorious drug of the twentieth century and the never-before-told story of its American survivors. Longlisted for the Andrew Carnegie Medal In 1959, a Cincinnati pharmaceutical firm, the William S. Merrell Company, quietly began distributing samples of an exciting new wonder drug already popular around the world. Touted as a sedative without risks, thalidomide was handed out freely, under the guise of clinical trials, by doctors who believed approval by the Food and Drug Administration was imminent. But in 1960, when the application for thalidomide landed on the desk of FDA medical reviewer Frances Kelsey, she quickly grew suspicious. When she learned that the drug was causing severe birth abnormalities abroad, she and a team of dedicated doctors, parents, and journalists fought tirelessly to block its authorization in the United States and stop its sale around the world.
Award History
0 wins · 1 total
| Award | Year | Result | Category / Notes |
|---|---|---|---|
| Andrew Carnegie Medal for Excellence in NonfictionMajor | 2024 | Longlist | Official source |
Experimental book profileGenerated by GPT-5.4 nano · may contain inaccuracies
This is an unverified interpretation of the catalog description, offered as an opt-in discovery experiment—not as bibliographic fact.
01 Central figures
- Frances Kelsey86%
02 Central places
None extracted with sufficient confidence.
These suggestions did not meet the normal display threshold and are more likely to be wrong.
- Cincinnati42%
03 Suggested argument
No argument inferred with sufficient confidence.
This suggestion did not meet the normal display threshold and is more likely to be wrong.
FDA medical reviewer Frances Kelsey’s suspicion of thalidomide’s abroad birth defects enabled efforts by doctors, parents, and journalists to block authorization in the United States and stop its sale worldwide.
Model confidence 55%
04 Reading orientation
38 / 100 academicSerious trade
An estimate of intended readership and scholarly apparatus—not quality or importance.
Confidence percentages are the model's own estimates. Profile confidence: 64%.